Navigation Links
Microbicide trial results a turning point for HIV prevention, says team testing same gel
Date:7/19/2010

Researchers who conducted a study testing a vaginal microbicide with an antiretroviral (ARV) drug called tenofovir found its use before and after sex was significantly more protective against HIV infection than a placebo gel among women at high risk of HIV. Results of the study, known as CAPRISA 004, are to be reported at the International AIDS Conference (AIDS 2010) in Vienna and published online by the journal Science.

CAPRISA 004 involved 889 women from Durban and a nearby rural community in South Africa, where women are at especially high risk of acquiring HIV through sexual intercourse. Women were randomly assigned to one of two study groups tenofovir gel or placebo gel with no active ingredient and instructed to use the study product in a regimen timed before and after sex. At the end of the study, there were 39 percent fewer HIV infections among women who used tenofovir gel before and after sex than among those who used the placebo gel. The study was conducted by the Centre for the AIDS Programme of Research in South Africa (CAPRISA).

"This study has established proof of concept that a vaginal microbicide containing an ARV can protect women from HIV. This is an incredibly important achievement for which the CAPRISA team is to be congratulated. For all of us in the HIV prevention field, this result has shown that it may be possible to leverage this initial success using a single ARV at the time of sex into more potent approaches that could be 50, 60 or even 70 percent effective for prevention of HIV. The results of this study have reinvigorated the field," commented Sharon Hillier, Ph.D., professor and vice chair for faculty affairs, and director of reproductive infectious disease research in the department of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine, and principal investigator of the Microbicide Trials Network (MTN).

The MTN currently is conducting another stu
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-916-3315
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Anthony S. Fauci, M.D., on results from the CAPRISA 004 microbicide study
2. Study of microbicide gel shows reduced risk of HIV and herpes infections in women
3. Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women
4. Press briefings at International Microbicides Conference May 22-25
5. Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials
6. BioSTARTM device achieves 90 percent closure rate for atrial septal defect in children
7. Hopkins faculty lead development of report to FDA on ethical, scientific issues related to post-market clinical trials
8. FDA Reviewer Questions Results of Key Avandia Trial
9. NOSCAR announces first NOTES transoral and transvaginal gallbladder removals performed as part of US multicenter human trial
10. University at Buffalo launches clinical trial of new multiple sclerosis treatment
11. Announcing: Intrinsic Imaging : Radiology Experts Launch Novel Medical Imaging CRO for Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... New York, New York (PRWEB) May 25, 2015 ... and distributor of patented products, launches The Preventer, a ... property from the dangers of fire. , "House fires ... yearly," says Scott J. Cooper, CEO and Creative Director ... of home fire deaths result from homes that have ...
(Date:5/25/2015)... World Patent Marketing, a vertically integrated ... Little Party Table, a party invention that gives people ... suit their party needs. , "Worldwide indoor and outdoor ... past year. Party Supply Rentals alone are a ... CEO and Creative Director of World Patent Marketing ...
(Date:5/25/2015)... 2015 World Patent Marketing, a vertically ... Hidee-Hose, an undergarment patent that allays women’s fears when ... Hosiery industry forecasts the market to reach $20.3 billion ... Director of World Patent Marketing , "The largest ... and is expected to maintain its lead. The industry ...
(Date:5/25/2015)... HomeCare is proud to announce that David Allerby, Co-Founder ... Iwamoto, Co-Founder & CMO, are Finalists for the Ernst ... Greater Los Angeles. The award is presented by EY ... and a personal commitment to their communities. , “Our ... of our organization,” said Co-Founder & CEO, David Allerby, ...
(Date:5/25/2015)... 2015 According to a recently published ... in hip external fixation market is driven by an ... and advancements in infection prevention technologies. As the population ... currently accounting for the largest total number of bone ... and accidents. As a result, the average selling price ...
Breaking Medicine News(10 mins):Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 3Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 3Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3
... meets tight deadlines and reduces costs , ... Portland, ... announced the launch of its PeerPoint® Medical Review Portal software. ... to send and receive independent medical reviews via the web. ...
... AIDS Vaccine, Microbicide and PrEP Research and Calls for Urgent ... May 18 "It,s an exciting time in HIV prevention ... important HIV prevention research trials this year, as well as ... will yield important answers in the years to come," said ...
... into muscles , , SUNDAY, May 17 -- Raising hopes ... actually work, researchers report they were able to protect ... primate version of HIV. , They did so by ... to the animals, muscles. Typically, vaccines are aimed at ...
... DIEGOA large, well-controlled, multi-national clinical trial program has ... become the first FDA-approved medicine for idiopathic pulmonary ... study program called "CAPACITY," investigators discovered that the ... the deterioration of lung capacity in patients suffering ...
... (May 17, 2009)The COPD Foundation announces launch of the ... WebMD. Development of the Lung Health Check was made ... , The Lung Health Check is an educational platform ... symptoms and risks of developing lung disease, and suggests ...
... to avoid being attacked , , SUNDAY, May 17 (HealthDay News) ... can be unpredictable, warns the American College of Emergency Physicians ... each year, according to the U.S. Centers for Disease Control ... In 2006, more than 31,000 people had to have reconstructive ...
Cached Medicine News:Health News:AllMed's New PeerPoint Medical Review Portal Improves Medical Review Process 2Health News:AllMed's New PeerPoint Medical Review Portal Improves Medical Review Process 3Health News:Piecing Together the HIV Prevention Puzzle 2Health News:Piecing Together the HIV Prevention Puzzle 3Health News:Piecing Together the HIV Prevention Puzzle 4Health News:Vaccine Shields Monkeys From Simian Form of HIV 2Health News:Vaccine Shields Monkeys From Simian Form of HIV 3Health News:Large clinical trial finds pirfenidone may help lung function in IPF patients 2Health News:Large clinical trial finds pirfenidone may help lung function in IPF patients 3Health News:COPD Foundation announces launch of Lung Health Check on WebMD 2Health News:Beware of Dog Bites 2
(Date:5/22/2015)... , May 22, 2015  Research and Benchmarking ... sixth Medical Affairs Roundtable on Thursday, ... a virtual roundtable to discuss "Medical Affairs, Role ... Best Practices, Medical Affairs Consortium provides Medical Affairs ... the key challenges they face. The consortium has ...
(Date:5/22/2015)... 22 2015 /CNW/ - The Taskforce representing Canada,s ... all the hard work that the Minister and Health Canada ... This program recognizes the needs of the thalidomide survivors, and ... a year, tax free, with annual adjustments for inflation. ... annual payments of $100,000 based on the severity of their ...
(Date:5/22/2015)... , May 22, 2015  Amgen ... Company has commenced termination of its participation ... with AstraZeneca (LON:AZN, STO:AZN and NYSE: ... is in development for patients with moderate-to-severe ... The decision was based on events of ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
Bravo Calibration Tubes...
The pouch is designed to protect the Digitrapper. The pouch strap can be worn on a belt loop or carried in a shoulder strap or backpack configuration....
pHix Strips easily fix the catheter on the nose and are made of microporous tape allowing the skin to breathe....
... proper gel is essential in ... working with pH catheters with ... chloride ion concentration in the ... for proper function of your ...
Medicine Products: